$1.52
0.00% yesterday
Nasdaq, Dec 30, 10:00 pm CET
ISIN
US0144421072
Symbol
ALEC

Alector, Inc. Stock price

$1.52
+0.29 23.58% 1M
+0.12 8.57% 6M
-0.37 19.58% YTD
-0.20 11.63% 1Y
-7.71 83.53% 3Y
-13.76 90.05% 5Y
-15.11 90.86% 10Y
-15.11 90.86% 20Y
Nasdaq, Closing price Tue, Dec 30 2025
+0.00 0.00%
ISIN
US0144421072
Symbol
ALEC
Industry

Key metrics

Basic
Market capitalization
$165.9m
Enterprise Value
$-115.6m
Net debt
positive
Cash
$291.1m
Shares outstanding
107.5m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
2.4 | 9.5
EV/Sales
negative | negative
EV/FCF
0.6
P/B
2.9
Financial Health
Equity Ratio
27.1%
Return on Equity
-93.9%
ROCE
-48.4%
ROIC
2,510.0%
Debt/Equity
0.2
Financials (TTM | estimate)
Revenue
$69.1m | $17.4m
EBITDA
$-117.1m | $-155.3m
EBIT
$-123.7m | $-165.6m
Net Income
$-107.7m | $-158.4m
Free Cash Flow
$-197.6m
Growth (TTM | estimate)
Revenue
12.3% | -82.7%
EBITDA
33.0% | -11.3%
EBIT
32.4% | -14.2%
Net Income
32.0% | -33.0%
Free Cash Flow
11.1%
Margin (TTM | estimate)
Gross
-
EBITDA
-169.5% | -892.4%
EBIT
-179.1%
Net
-156.0% | -909.8%
Free Cash Flow
-286.2%
More
EPS
$-1.1
FCF per Share
$-1.8
Short interest
7.2%
Employees
238
Rev per Employee
$420.0k
Show more

Is Alector, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,083 stocks worldwide.

Alector, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

14 Analysts have issued a Alector, Inc. forecast:

1x Buy
7%
8x Hold
57%
5x Sell
36%

Analyst Opinions

14 Analysts have issued a Alector, Inc. forecast:

Buy
7%
Hold
57%
Sell
36%

Financial data from Alector, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
69 69
12% 12%
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 56 56
3% 3%
81%
- Research and Development Expense 137 137
27% 27%
198%
-117 -117
33% 33%
-170%
- Depreciation and Amortization 6.63 6.63
19% 19%
10%
EBIT (Operating Income) EBIT -124 -124
32% 32%
-179%
Net Profit -108 -108
32% 32%
-156%

In millions USD.

Don't miss a Thing! We will send you all news about Alector, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Alector, Inc. Stock News

Neutral
GlobeNewsWire
18 days ago
SOUTH SAN FRANCISCO, Calif., Dec. 12, 2025 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company focused on developing therapies to counteract the devastating progression of neurodegeneration, today announced that Neil Berkley, who has served as Alector's Chief Business Officer (CBO) since March 2024, and CBO and Interim Chief Financial Officer (CFO) since Jun...
Neutral
Seeking Alpha
22 days ago
Alector, Inc. (ALEC) Presents at BofA Securities CNS Therapeutics Virtual Conference 2025 Transcript
Neutral
GlobeNewsWire
29 days ago
SOUTH SAN FRANCISCO, Calif., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company focused on developing therapies to counteract the devastating progression of neurodegeneration, today announced that management will participate in a fireside chat at the Bank of America CNS Therapeutics Conference, being held virtually on Monday, December 8, 2025,...
More Alector, Inc. News

Company Profile

Alector, Inc. operates as a clinical-stage biopharmaceutical company. It develops therapeutics for the treatment of neurodegenerative diseases including frontotemporal dementia (FTD), Alzheimer's disease, and Parkinson's disease. The company was founded by Asa Abeliovich, Errik B. Anderson, Tillman U. Gerngross, and Arnon Rosenthal in May 2013 and is headquartered in South San Francisco, CA.

Head office United States
CEO Arnon Rosenthal
Employees 238
Founded 2013
Website alector.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today